| RS2030444679 |
L2HGDH
|
Health Risk |
Likely pathogenic |
L-2-hydroxyglutaric aciduria, Abnormality of metabolism/homeostasis |
| RS2030528716 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2030617696 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS2030619513 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2, Usher syndrome type 2A |
| RS2030621345 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2030687889 |
TAOK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental delay with or without intellectual impairment or behavioral abnormalities, Developmental delay with or without intellectual impairment or behavioral abnormalities |
| RS2030755066 |
SLC40A1
|
Health Risk |
Pathogenic |
Hemochromatosis type 4, Hemochromatosis type 4 |
| RS2030770130 |
ACE
|
Health Risk |
Pathogenic |
— |
| RS2030785010 |
SMARCB1
|
Health Risk |
Likely pathogenic |
— |
| RS2030789446 |
SMARCB1
|
Health Risk |
Pathogenic |
— |
| RS2030790572 |
SMARCB1
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 1, SMARCB1-related disorder |
| RS2030801584 |
AIFM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe X-linked mitochondrial encephalomyopathy, Combined oxidative phosphorylation deficiency |
| RS2030965698 |
TOR1A
|
Health Risk |
Pathogenic |
Arthrogryposis multiplex congenita 5, Arthrogryposis multiplex congenita 5 |
| RS2030976698 |
TAOK1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2030989355 |
TAOK1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, DEVELOPMENTAL DELAY WITHOUT INTELLECTUAL IMPAIRMENT OR BEHAVIORAL ABNORMALITIES |
| RS2031075939 |
CYP19A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Aromatase deficiency, Aromatase excess syndrome |
| RS2031080312 |
TAOK1
|
Health Risk |
Pathogenic |
Developmental delay with or without intellectual impairment or behavioral abnormalities, Developmental delay with or without intellectual impairment or behavioral abnormalities |
| RS2031089646 |
KDM6A
|
Health Risk |
Pathogenic |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS2031121154 |
HSF4
|
Health Risk |
Likely pathogenic |
HSF4-related disorder, HSF4-related disorder |
| RS2031257693 |
PET100
|
Health Risk |
Likely pathogenic |
Mitochondrial complex IV deficiency, nuclear type 12 |
| RS2031258865 |
PET100
|
Health Risk |
Pathogenic |
— |
| RS2031334549 |
NONO
|
Health Risk |
Likely pathogenic |
Heart, malformation of |
| RS2031389522 |
NONO
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability 34, Syndromic X-linked intellectual disability 34 |
| RS2031394526 |
ATR
|
Health Risk |
Pathogenic |
— |
| RS2031437544 |
TPM1
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, TPM1-related disorder |
| RS2031445986 |
TPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy |
| RS2031447940 |
PPM1D
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2031449441 |
PPM1D
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2031451980 |
KIZ
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 69, Retinitis pigmentosa 69 |
| RS2031456898 |
NONO
|
Health Risk |
Likely pathogenic |
Syndromic X-linked intellectual disability 34, Syndromic X-linked intellectual disability 34 |
| RS2031508845 |
NONO
|
Health Risk |
Likely pathogenic |
Syndromic X-linked intellectual disability 34, Syndromic X-linked intellectual disability 34 |
| RS2031551111 |
PPM1D
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold |
| RS2031551420 |
PPM1D
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2031551570 |
PPM1D
|
Health Risk |
Likely pathogenic |
— |
| RS2031551625 |
PPM1D
|
Health Risk |
Pathogenic |
— |
| RS2031551741 |
PPM1D
|
Health Risk |
Pathogenic |
— |
| RS2031551825 |
PPM1D
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold, Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold |
| RS2031551927 |
PPM1D
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold, Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold |
| RS2031554958 |
PPM1D
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold, Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold |
| RS2031555258 |
PPM1D
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold, Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold |
| RS2031562776 |
PPM1D
|
Health Risk |
Likely pathogenic |
— |
| RS2031564242 |
PPM1D
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold, Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold |
| RS2031604509 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 39 |
| RS2031609360 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2031617950 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2031620246 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2031623445 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2031759596 |
ACTG1
|
Health Risk |
Pathogenic |
Baraitser-winter syndrome 2, Microcephaly |
| RS2031770749 |
ACTG1
|
Health Risk |
Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 20, Autosomal dominant nonsyndromic hearing loss 20 |
| RS2031775804 |
ACTG1
|
Health Risk |
Likely pathogenic |
Baraitser-winter syndrome 2, Baraitser-winter syndrome 2 |
| RS2031777349 |
TRPM1
|
Health Risk |
Pathogenic |
Congenital stationary night blindness 1C, Congenital stationary night blindness 1C |
| RS2031815415 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2031844309 |
STXBP2
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2031853048 |
TPM1
|
Health Risk |
Likely pathogenic |
— |
| RS2031855864 |
ACTG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, ACTG1-related disorder |
| RS2031863455 |
TPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS2031907358 |
STXBP2
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2031929480 |
DLD
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS2031930307 |
DLD
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS2031931706 |
ADAMTS17
|
Health Risk |
Likely pathogenic |
— |
| RS2031932785 |
STXBP2
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2031934299 |
TAOK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder, Developmental delay with or without intellectual impairment or behavioral abnormalities |
| RS2031936282 |
TAOK1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2031953051 |
DNMT3A
|
Health Risk |
Likely pathogenic |
— |
| RS2031967126 |
THRB
|
Health Risk |
Likely pathogenic |
— |
| RS2031982524 |
DLD
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS2032004082 |
DLD
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS2032018454 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2032019895 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS2032068125 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2032072206 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2032074764 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2032078984 |
ERCC4
|
Health Risk |
Pathogenic |
— |
| RS2032088471 |
STXBP2
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2032092446 |
RAI1
|
Health Risk |
Pathogenic |
— |
| RS2032102818 |
RAI1
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2032103883 |
RAI1
|
Health Risk |
Likely pathogenic |
— |
| RS2032105178 |
RAI1
|
Health Risk |
Pathogenic |
RAI1-related disorder, RAI1-related disorder |
| RS2032120646 |
RAI1
|
Health Risk |
Pathogenic |
— |
| RS2032121558 |
RAI1
|
Health Risk |
Likely pathogenic |
Smith-Magenis syndrome, Smith-Magenis syndrome |
| RS2032146977 |
RAI1
|
Health Risk |
Pathogenic |
— |
| RS2032147505 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2032148329 |
LOXHD1
|
Health Risk |
Likely pathogenic |
— |
| RS2032151441 |
RAI1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2032155264 |
ERCC4
|
Health Risk |
Pathogenic |
Cockayne syndrome, Fanconi anemia complementation group Q |
| RS2032158187 |
RAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2032164364 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS2032172594 |
RAI1
|
Health Risk |
Likely pathogenic |
Intellectual disability, Smith-Magenis syndrome |
| RS2032173863 |
STXBP2
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2032173917 |
STXBP2
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2032190831 |
TRIP12
|
Health Risk |
Likely pathogenic |
— |
| RS2032191781 |
KIZ
|
Health Risk |
Pathogenic |
— |
| RS2032191929 |
RAI1
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Smith-Magenis syndrome |
| RS2032195039 |
KIZ
|
Health Risk |
Pathogenic |
— |
| RS2032214426 |
TRIP12
|
Health Risk |
Conflicting classifications of pathogenicity |
Clark-Baraitser syndrome, Clark-Baraitser syndrome |
| RS2032220637 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2032220940 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2032221370 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2032221850 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS2032234525 |
RAI1
|
Health Risk |
Pathogenic |
Smith-Magenis syndrome, Smith-Magenis syndrome |